Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,129–4,136 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Ultragenyx Pharmaceutical Inc. DOJOLVI (triheptanoin) Glut1 DS patients with the movement disorder phenotype Phase 3 Trial Discontinued Oral Genetic Disorder
Ultragenyx Pharmaceutical Inc. Aceneuramic acid extended release (Ace-ER) GNE Myopathy Phase 3 Trial Discontinued Oral Genetic Disorder
Ultragenyx Pharmaceutical Inc. DTX301 - (Enh3ance) Ornithine Transcarbamylase (OTC) Deficiency Phase 3 Ongoing Intravenous Genetic Disorder
Ultragenyx Pharmaceutical Inc. DOJOLVI (triheptanoin) Glut1 DS patients with the movement disorder phenotype Phase 3 Trial Discontinued Oral Genetic Disorder
Ultragenyx Pharmaceutical Inc. Aceneuramic acid extended release (Ace-ER) GNE Myopathy Phase 3 Trial Discontinued Oral Genetic Disorder
Ultragenyx Pharmaceutical Inc. GTX-102 - (Aurora) Other Angelman syndrome genotypes Phase 3 Trial Planned Intrathecal Genetic Disorder
Ultragenyx Pharmaceutical Inc. GTX-102 - (Aurora) Angelman syndrome (AS) Phase 2/3 Ongoing Intrathecal Genetic Disorder
Ultragenyx Pharmaceutical Inc. Setrusumab (BPS-804) - (ORBIT) Osteogenesis Imperfecta Phase 2/3 Data Released Intravenous Orthopedic